Chemoinformaics analysis of 6-Methylhept-5-en-3-one
| Molecular Weight | 126.199 | nRot | 3 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 2 |
| Exact Molecular Weight | 126.104 | nRing | 0 |
| Solubility: LogS | -1.844 | nHRing | 0 |
| Solubility: LogP | 2.289 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.4971 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.53 |
| Synth | 2.821 |
| Natural Product Likeliness | 1.404 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.303 |
| MDCK | 0.0000327 |
| BBB | 0.993 |
| PPB | 0.879293 |
| VDSS | 0.694 |
| FU | 0.164713 |
| CYP1A2-inh | 0.405 |
| CYP1A2-sub | 0.41 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.273 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.433 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.391 |
| CL | 10.578 |
| T12 | 0.771 |
| hERG | 0.019 |
| Ames | 0.247 |
| ROA | 0.739 |
| SkinSen | 0.84 |
| Carcinogencity | 0.893 |
| EI | 0.979 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.95289 |